Altered reactivity to norepinephrine through COX-2 induction by vascular injury in hypercholesterolemic rabbits (Q43270601)

17 November 2017

title

Altered reactivity to norepinephrine through COX-2 induction by vascular injury in hypercholesterolemic rabbits (English)

1 reference

17 November 2017

0 references

0 references

7

1 reference

17 November 2017

Xavier Norel

2

0 references

Nabil Foudi

object named as

Nabil Foudi

1

0 references

author name string

Mario Rienzo

3

1 reference

17 November 2017

Liliane Louedec

4

1 reference

17 November 2017

Charles Brink

5

1 reference

17 November 2017

Jean-Baptiste Michel

6

1 reference

17 November 2017

publication date

25 September 2009

1 reference

American Journal of Physiology Heart and Circulatory Physiology

17 November 2017

published in

1 reference

17 November 2017

volume

297

1 reference

17 November 2017

issue

5

1 reference

17 November 2017

page(s)

H1882-8

1 reference

Cyclo-oxygenase-2, endothelium and aortic reactivity during deoxycorticosterone acetate salt-induced hypertension

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Inflammatory signaling through leukotriene receptors in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Arterial prostaglandins and lysosomal function during atherogenesis. I. Homogenates of diet-induced atherosclerotic aortas of rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Interleukin-1beta, transforming growth factor-beta1, and bradykinin attenuate cyclic AMP production by human pulmonary artery smooth muscle cells in response to prostacyclin analogues and prostaglandin E2 by cyclooxygenase-2 induction and downregula

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

The structures of prostaglandin endoperoxide H synthases-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

The immune response in atherosclerosis: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Prostanoid receptors in the human vascular wall.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Prostacyclin release and receptor activation: differential control of human pulmonary venous and arterial tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Evidence that a prostanoid produced by cyclo-oxygenase-2 enhances contractile responses of the porcine isolated coronary artery following exposure to lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Effects of COX-2 inhibitors on aortic prostacyclin production in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

Cyclooxygenase- and lipoxygenase-dependent relaxation to arachidonic acid in rabbit small mesenteric arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00092.2009

10.1152/AJPHEART.00092.2009

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference